JPMorgan has identified a new cohort of 'meme stocks' – Hims & Hers Health, ImmunityBio, Rocket Companies, and SoundHound AI – characterized by high social media engagement, strong retail buying interest, and elevated hedge fund short positions. The firm warns these names are prone to significant volatility and potential short squeezes due to these opposing investor dynamics, especially within a bullish market. For instance, Rocket Companies recently received a Bank of America upgrade, while Hims & Hers Health experienced a Q2 revenue miss and competitive pressures.
JPMorgan has identified a new set of potential 'meme stocks'—Hims & Hers Health (HIMS), ImmunityBio (IBRX), Rocket Companies (RKT), and SoundHound AI (SOUN)—characterized by a volatile combination of high retail investor buying and significant short interest from hedge funds. This dynamic creates a fertile ground for unexpected price swings and potential short squeezes, a phenomenon amplified by the current bullish market backdrop. The fundamental drivers for these companies are notably divergent. Rocket Companies, for example, recently hit a 52-week high following a Bank of America upgrade, which cited the firm as a key beneficiary of future interest rate cuts. Conversely, Hims & Hers Health is facing headwinds after a Q2 revenue miss and competitive pressure from Novo Nordisk, which likely contributes to its elevated short interest. This divergence underscores that while these stocks are grouped by technical and sentiment factors, their underlying business prospects differ significantly, making them a high-risk, high-volatility cohort.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
0.00
Ticker Sentiment